Literature DB >> 192162

Insulin receptor status in disease states of man.

R S Bar, J Roth.   

Abstract

When insulin or any peptide hormone binds to its receptor on the surface of a target cell, it initiates a series of biochemical steps that ultimately lead to the characteristic action of the hormone. The strength of the signal generated by the hormone depends equally on the hormone concentration, the receptor concentration, and the receptor affinity. Not only do hormone concentrations change rapidly and widely in vivo but so do receptor concentration and affinity. In hormone resistant states, any step in the biochemical pathway of hormone action at the target cell may be involved. Studies of insulin receptors in people indicate that the insulin receptor is altered in many common disorders such as obesity and diabetes, as well as in rare disorders such as extreme insulin resistance due to circulating antibodies directed at the insulin receptor itself. By responding to both intracellular and extracellular events, the insulin receptor is, therefore, a major site for the regulation of target cell responsiveness in vivo.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192162

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

1.  Autoantibodies to the insulin receptor activate glycogen synthase in rat adipocytes.

Authors:  J C Lawrence; J Larner; C R Kahn; J Roth
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

Review 2.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

3.  Glucocorticoid receptors and depression.

Authors:  L J Whalley; N Borthwick; D Copolov; H Dick; J E Christie; G Fink
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-29

Review 4.  [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].

Authors:  W Gerok
Journal:  Klin Wochenschr       Date:  1979-06-15

5.  Receptor dysfunctions in human disease.

Authors:  L H Block; W Tenschert; R Locher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-04-15

6.  Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry.

Authors:  J P Felber; H U Meyer; B Curchod; H U Iselin; J Rousselle; E Maeder; P Pahud; E Jéquier
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

7.  Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat.

Authors:  F W Kemmer; M Berger; L Herberg; F A Gries; A Wirdeier; K Becker
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

8.  Hormone-receptor interactions are noncooperative: application to the beta-adrenergic receptor.

Authors:  R J Pollet; M L Standaert; B A Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Medical complications of obesity.

Authors:  A Angel; D A Roncari
Journal:  Can Med Assoc J       Date:  1978-12-23       Impact factor: 8.262

10.  Hepatic ultrastructure in leprechaunism. Hepatic ultrastructural evidence suggesting a syndrome with defective hepatic glucose release.

Authors:  S I Roth; H K Schedewie; D M Bier; H H Conaway; J Olefsky; A Rubenstein; M J Elders
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.